01—Abstract
Summary
Summary of the 8-K filed March 10, 2025. Cited figures are marked; the original filing is the authoritative source.
Cardinal Health (NYSE: CAH) filed a Form 8-K on March 10, 2025 to disclose that its Board of Directors elected two new independent directors, Robert W.
Musslewhite and Sudhakar Ramakrishna, effective March 7, 2025. This is a governance update rather than a financial disclosure: the filing contains no financial results, guidance, transaction terms, or material operational changes. Both directors will serve until the 2025 annual meeting of shareholders, and the Board has determined that each is independent under NYSE rules and the Exchange Act.
Mr. Musslewhite, former CEO of Definitive Healthcare Corp. and previously of OptumInsight and The Advisory Board Company, joins the Audit and Human Resources and Compensation Committees. He brings experience in healthcare data, analytics, and technology. Mr. Ramakrishna, President and CEO of SolarWinds Corporation, joins the Audit and Risk Oversight Committees and brings technology leadership and cybersecurity expertise, which is relevant to a company with large, complex distribution and data operations.
For investors, the filing signals a board refresh with a focus on technology, data, and cybersecurity, areas the company's leadership said will be important as its operating environment evolves. Both directors receive compensation consistent with other non-employee directors, and the filing discloses no related-party transactions under Item 404(a). The appointments are unlikely to have a near-term impact on earnings or valuation, but they may matter for oversight of technology and risk as the company executes its strategy.
02—Key points
Key Highlights
- Cardinal Health's Board elected Robert W. Musslewhite and Sudhakar Ramakrishna as independent directors, effective March 7, 2025.
- Mr. Musslewhite, former CEO of Definitive Healthcare Corp., joins the Audit and Human Resources and Compensation Committees, bringing healthcare analytics and data expertise.
- Mr. Ramakrishna, President and CEO of SolarWinds Corporation, joins the Audit and Risk Oversight Committees, bringing technology and cybersecurity leadership.
- Both directors serve until the 2025 annual shareholder meeting and receive non-employee director compensation, per the 2024 proxy statement.
- The Board affirmatively determined both directors meet NYSE and Exchange Act independence standards.
- No related-party transactions requiring disclosure under Item 404(a) of Regulation S-K were identified.
- The filing contains no financial results, guidance, or material transaction disclosures; the change is governance-focused.
03—Questions
Frequently Asked Questions
Does this 8-K contain any financial results or guidance?
No. The filing covers only board appointments (Item 5.02) and a press release furnished under Regulation FD (Item 7.01). It includes no earnings, revenue, margin, or guidance information.
Why are these directors being added?
The company's press release cites their experience in technology, data and analytics, cybersecurity, and business strategy. Chairman Gregory Kenny and CEO Jason Hollar said the directors will help the board navigate complex and rapidly evolving environments.
Are the new directors independent?
Yes. The Board affirmatively determined that both Mr. Musslewhite and Mr. Ramakrishna are independent under NYSE rules and the Exchange Act.
Do the new directors receive special compensation or have related-party interests?
Neither. They receive the same compensation as other non-employee directors, as described in the 2024 proxy statement, and the company reported no transactions requiring disclosure under Item 404(a).
Could these appointments affect Cardinal Health's near-term performance?
Not directly. Board appointments of this kind typically have minimal immediate financial impact. Investors may watch how the new directors contribute to oversight of technology, data, cybersecurity, and risk over time.
04—Continue